Brief: Clearmind Medicine Announces Successful Completion Of Treatment Of Cmnd-100 For Alcohol Use Disorder
30/03/2026 15:08
March 30 (Reuters) - Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE ANNOUNCES SUCCESSFUL COMPLETION OF TREATMENT AND FOLLOW-UP FOR 18 PARTICIPANTS IN ITS ONGOING PHASE I/IIA CLINICAL TRIAL OF CMND-100 FOR ALCOHOL USE DISORDER Source text: ID:nGNX3HMYcb Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM